Osaic Holdings
UTHR icon

Osaic Holdings’s United Therapeutics UTHR Stock Holding History

Osaic Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.83M Buy
10,752
+6,223
+137% +$3.5M 0.01% 1423
2026
Q1 		$2.69M Sell
4,529
-6,469
-59% -$3.22M ﹤0.01% 1830
2025
Q4 		$5.36M Sell
10,998
-37,385
-77% -$17.4M 0.01% 1326
2025
Q3 		$20.1M Buy
48,383
+2,301
+5% +$774K 0.03% 615
2025
Q2 		$14M Buy
46,082
+33,662
+271% +$10.1M 0.03% 654
2025
Q1 		$3.83M Sell
12,420
-3,310
-21% -$1.13M 0.01% 1204
2024
Q4 		$4.55M Buy
15,730
+1,294
+9% +$476K 0.01% 1086
2024
Q3 		$5.17M Buy
14,436
+2,105
+17% +$711K 0.01% 1018
2024
Q2 		$3.93M Sell
12,331
-1,254
-9% -$332K 0.01% 1158
2024
Q1 		$3.12M Sell
13,585
-18,774
-58% -$4.24M 0.01% 1374
2023
Q4 		$7.12M Sell
32,359
-1,915
-6% -$441K 0.01% 975
2023
Q3 		$7.74M Buy
34,274
+24,054
+235% +$5.54M 0.01% 1005
2023
Q2 		$2.26M Sell
10,220
-89
-0.9% -$19.7K ﹤0.01% 1757
2023
Q1 		$2.31M Sell
10,309
-4,303
-29% -$1.06M ﹤0.01% 1709
2022
Q4 		$4.06M Buy
14,612
+8,887
+155% +$2.24M 0.01% 1243
2022
Q3 		$1.2M Buy
5,725
+463
+9% +$104K ﹤0.01% 2050
2022
Q2 		$1.24M Sell
5,262
-230
-4% -$46.8K ﹤0.01% 2072
2022
Q1 		$1.3M Sell
5,492
-498
-8% -$94.9K ﹤0.01% 2330
2021
Q4 		$1.29M Buy
5,990
+2,731
+84% +$536K ﹤0.01% 2151
2021
Q3 		$603K Buy
3,259
+208
+7% +$41K ﹤0.01% 2850
2021
Q2 		$548K Buy
3,051
+161
+6% +$30.7K ﹤0.01% 2931
2021
Q1 		$487K Buy
2,890
+290
+11% +$48.4K ﹤0.01% 2891
2020
Q4 		$396K Sell
2,600
-50
-2% -$6.56K ﹤0.01% 2861
2020
Q3 		$274K Buy
2,650
+143
+6% +$15.7K ﹤0.01% 2968
2020
Q2 		$303K Buy
2,507
+1,388
+124% +$156K ﹤0.01% 2771
2020
Q1 		$108K Buy
+1,119
New +$106K ﹤0.01% 3413

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Osaic Holdings's UTHR Position: Q2 2026 in Review

Osaic Holdings increased its United Therapeutics (UTHR) stake by 137% in Q2 2026, buying an estimated $3.5M and bringing the position to 10,752 shares worth $5.83M. The position accounts for 0.01% of the portfolio, ranked #1423.

Osaic Holdings first reported a position in UTHR in Q1 2020 and has held it in 26 quarters since. The position peaked at $20.1M in Q3 2025. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Osaic Holdings held 10,752 shares of United Therapeutics worth $5.83M as of Q2 2026.
  • Osaic Holdings bought 6,223 United Therapeutics shares in Q2 2026, an estimated $3.5M.
  • United Therapeutics made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1423 holding.
  • Osaic Holdings first reported a position in United Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's United Therapeutics position peaked at $20.1M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.